Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Health & Fitness
Eli Lilly’s scope in neuroscience is broadening to psychedelics through a deal to buy AtaiBeckley, a clinical-stage company whose lead program might offer advantages…
The entry story has been told. Goldman Sachs and Charlesbank…
The GLP-1 era is here. The drugs are working. The…
Almost every healthcare AI pilot I have seen clear its success criteria has gone on…
Healthcare workforce strategy has long centered on reducing, responding to and recovering from turnover. That’s…
The case for AI-powered documentation tools has moved from theory to data. By mid-2025, 62.6…
Anthropic is rolling out Claude Science, an AI workbench for pharma researchers. The buzzy AI…
It’s been a busy few months for Servier, which followed its $2.5 billion acquisition of…
Zelis, a healthcare technology company, launched a new AI solution last week that seeks to…
Don't Miss
By Allison Jones The Canadian Press Posted July 16, 2026 3:35 pm 1 min read…
Subscribe to Updates
Get the latest creative news from SmartMag about art & design.